Literature DB >> 1965658

Pre- and postsynaptic adrenergic dysfunctions in hypertension.

J de Champlain1.   

Abstract

Numerous experimental and clinical studies, using various approaches to evaluate the release of sympathetic transmitters and to obtain sympathetic nerve microneurographic recordings, have shown clearly that sympathetic system activity and reactivity is increased in experimental models of hypertension [deoxycorticosterone acetate (DOCA) salt and spontaneously hypertensive rats (SHR)] and in an important subgroup of essential hypertensive patients. This finding may reflect dysfunctions in the baroreflex blood pressure regulation, since an elevated blood pressure should normally inhibit sympathetic activity. This abnormality may arise from a variety of dysfunctions occurring at various sites along the baroreflex arc, including presynaptic modulatory adrenergic autoreceptors, where reduced sensitivity of presynaptic alpha 2 inhibitory receptors and enhanced sensitivity of beta 2 presynaptic receptors have been demonstrated. Although it has been possible to correlate the blood pressure elevation with various indices of sympathetic activity in experimental and human hypertension, the functional implications of that abnormality can be fully understood only in the light of concomitant alterations occurring in postsynaptic mechanisms. Pharmacologic, physiologic and biochemical studies strongly suggest that postsynaptic alpha 1 adrenergic functions become dominant while beta adrenergic functions are attenuated in hypertension. In experimental hypertension, this phenomenon is associated with a reduction in the number of beta adrenoceptors and in the production of its second messenger, cyclic AMP, whereas the number of alpha 1 adrenoceptors remained unchanged or increased, but the production of their second messengers, inositol triphosphate and diacylglycerol, is enhanced in cardiac and vascular tissues. These observations suggest the presence of an imbalance in postsynaptic adrenoceptor functions, which promotes the pressor effects of the sympathetic system.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1965658

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  16 in total

1.  Role of alpha adrenoceptors and nitric oxide on cardiovascular responses in acute and chronic hypertension.

Authors:  Enrique Hong; Francisco Larios; Norma L Gómez-Viquez; Fengyang Huang; Guadalupe Bravo
Journal:  J Physiol Biochem       Date:  2011-04-15       Impact factor: 4.158

2.  Impact of Racial Discrimination and Hostility on Adrenergic Receptor Responsiveness in African American Adults.

Authors:  LaBarron K Hill; Andrew Sherwood; Maya McNeilly; Norman B Anderson; James A Blumenthal; Alan L Hinderliter
Journal:  Psychosom Med       Date:  2018 Feb/Mar       Impact factor: 4.312

Review 3.  Do most antihypertensive agents have a sympatholytic action?

Authors:  J de Champlain
Journal:  Curr Hypertens Rep       Date:  2001-08       Impact factor: 5.369

4.  Role of endothelin and vasopressin in DOCA-salt hypertension.

Authors:  M Yu; V Gopalakrishnan; J R McNeill
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

5.  Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed.

Authors:  Mirnela Byku; Heather Macarthur; Thomas C Westfall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-20       Impact factor: 4.733

6.  Augmented sensory-motor vasodilatation of the rat mesenteric arterial bed after chronic infusion of the P1-purinoceptor antagonist, DPSPX.

Authors:  V Relevic; A Rubino; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  The effect of yohimbine on sympathetic responsiveness in essential hypertension.

Authors:  C Damase-Michel; M A Tran; M E Llau; F Chollet; J M Senard; B Guiraud-Chaumeil; J L Montastruc; P Montastruc
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Nerve stimulation induced overflow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats.

Authors:  Mirnela Byku; Heather Macarthur; Thomas C Westfall
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

9.  Relationships between kallikrein secretion, kallikrein excretion and beta-adrenoceptors in kidney cortical slices from neurogenic hypertensive dogs.

Authors:  C Damase-Michel; G Bompart; G Durrieu; J L Montastruc; P Montastruc; J P Girolami
Journal:  Br J Pharmacol       Date:  1995-09       Impact factor: 8.739

10.  Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Authors:  Frank Cloutier; Brice Ongali; Maria M Campos; Gaétan Thibault; Witold Neugebauer; Réjean Couture
Journal:  Br J Pharmacol       Date:  2004-04-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.